Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer
Article Abstract:
Men with moderate to advanced prostate cancer may benefit from radiation therapy plus androgen suppression therapy, according to a study of 1,586 men. Hormones often stimulate cancer growth, so drugs are used to suppress hormone production.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Androgen suppression and radiation vs radiation alone for prostate cancer
Article Abstract:
A comparative study of the androgen suppression therapy (AST) and radiation therapy (RT) used for the treatment of prostate cancer is presented. The results show that AST leads to an increase in the overall survival in men with cancer.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Article Abstract:
Interstitial radiation (implant) therapy may be as effective as other prostate cancer treatments in men with mild disease but not in men with more severe disease. The radioactive implants can be used to treat a tumor that has not metastasized. Researchers compared implant therapy with radical prostatectomy (RP) or external beam radiation (RT) in 1,872 men with prostate cancer. All three treatments produced similar outcomes in men with mild disease but RP and RT provided better outcomes than radioactive implants in men with more severe disease.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer
- Abstracts: Disclosure to the reader of institutional review board approval and informed consent. The Contributions of Authors
- Abstracts: Periinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the International Amnioreduction Registry
- Abstracts: Restorative dentistry for pediatric teeth: state of the art 2001. Curing restorative resin: a significant controversy
- Abstracts: Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti - inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis: The CLASS Study: A Randomized Controlled Trial